| New possibilities in anticoagulant management of atrial fibrillation. | Rev Cardiovasc Med | 2004 | 15619613 |
| Hyperhomocysteinemia and B-vitamin status after discontinuation of oralanticoagulation therapy in patients with a history of venous thromboembolism. | Clin Chem Lab Med | 2003 Nov | 14656031 |
| Multivitamin supplements may affect warfarin anticoagulation in susceptiblepatients. | Ann Pharmacother | 2003 Nov | 14565795 |
| Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A,N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail". | Clin Pharmacol Ther | 2003 Nov | 14586384 |
| Ximelagatran versus warfarin for stroke prevention in patients with nonvalvularatrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study. | J Am Coll Cardiol | 2003 May 7 | 12742279 |
| Use of complementary and alternative medical therapies in patients with cardiovascular disease. | Am Heart J | 2003 May | 12766736 |
| The coagulation system contributes to synergistic liver injury from exposure to monocrotaline and bacterial lipopolysaccharide. | Toxicol Sci | 2003 Aug | 12773766 |
| Constituents of Peucedanum zenkeri seeds and their antimicrobial effects. | Pharmazie | 2003 Aug | 12967040 |
| Lopinavir/ritonavir: a review of its use in the management of HIV infection. | Drugs | 2003 | 12662125 |
| Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. | Clin Pharmacokinet | 2003 | 14531724 |